#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13252	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2030	648.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1396	1396	C	731	C	662	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23814	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3418	694.0	0	.	n	.	0	A20C	SNP	20	20	A	307	307	C	392	C,A	371,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23814	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3418	694.0	0	.	n	.	0	T695C	SNP	695	695	T	982	982	C	760	C	693	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23814	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3418	694.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1925	1925	G	794	G,A	723,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23814	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3418	694.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2258	2258	C	760	C,T,A	692,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23814	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3418	694.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2332	2332	A	777	A	719	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23814	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3418	694.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2884	2884	C	767	C	700	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	16	blaTEM	861	241	100.0	blaTEM.l15.c30.ctg.1	376	2.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1664	folP	855	855	100.0	folP.l15.c4.ctg.1	1427	116.1	1	SNP	p	R229S	1	.	.	685	687	AGC	997	999	AGC	154;153;155	A;G;C	144;144;145	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4618	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3286	140.1	1	SNP	p	S91F	1	.	.	271	273	TTC	501	503	TTC	171;173;173	T;T;C	152;154;153	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4618	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3286	140.1	1	SNP	p	G95N	0	.	.	283	285	GGC	513	515	GGC	177;178;179	G;G,C;C	154;154,1;153	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4618	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3286	140.1	1	SNP	p	D95G	1	.	.	283	285	GGC	513	515	GGC	177;178;179	G;G,C;C	154;154,1;153	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1414	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1222	114.9	0	.	p	.	0	F184L	NONSYN	550	552	TTC	877	879	TTG	165;166;166	T;T;G,C	150;153;149,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1414	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1222	114.9	1	SNP	p	G45D	0	.	.	133	135	GGC	460	462	GGC	205;202;202	G;G;C	185;183;185	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	734	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	874	83.3	0	.	n	.	0	A197.	DEL	197	197	A	520	520	A	172	A	158	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4770	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2887	164.6	1	SNP	p	D86N	0	.	.	256	258	GAC	541	543	GAC	207;208;210	G;A;C	184;184;187	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4770	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2887	164.6	1	SNP	p	R87I	0	.	.	259	261	CGT	544	546	CGT	213;216;220	C;G;T	189;192;193	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4770	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2887	164.6	1	SNP	p	R87W	0	.	.	259	261	CGT	544	546	CGT	213;216;220	C;G;T	189;192;193	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4770	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2887	164.6	1	SNP	p	S87R	1	.	.	259	261	CGT	544	546	CGT	213;216;220	C;G;T	189;192;193	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4770	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2887	164.6	1	SNP	p	S88P	0	.	.	262	264	TCC	547	549	TCC	219;217;217	T;C;C	195;192;195	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3890	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2485	156.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1477	1479	GGC	176;175;175	G;G;C	162;161;159	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3434	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2537	134.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1309	1311	GCA	194;194;194	G;C;A	170;171;172	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3434	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2537	134.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1312	1314	ATC	192;196;198	A;T;C	171;173;177	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3434	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2537	134.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1324	1326	GTG	190;191;189	G;T;G	168;171;170	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3434	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2537	134.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1324	1326	GTG	190;191;189	G;T;G	168;171;170	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3434	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2537	134.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1828	1830	ACC	181;178;178	A;C;C	167;164;167	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3434	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2537	134.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1882	1884	GCG	177;179;178	G;C;G	145;136;138	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3434	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2537	134.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1882	1884	GCG	177;179;178	G;C;G	145;136;138	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3434	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2537	134.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2005	2007	AGC	145;145;144	A;G;C	134;136;132	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3434	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2537	134.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2014	2016	GGC	143;143;140	G;G;C	131;132;130	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3434	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2537	134.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2032	2034	CCG	135;136;137	C,G;CG,CGG;G	94,3;92,1;96	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5128	ponA	2397	2397	99.92	ponA.l6.c30.ctg.1	3059	166.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1557	1559	CTG	203;205;205	C;T;G	179;186;183	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1896	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1650	114.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	489	489	C	124	C	110	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	300	porB1a	984	294	90.6	porB1a.l15.c30.ctg.2	383	28.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	114	116	AAT	12;12;12	A,C;A;T	11,1;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	300	porB1a	984	294	90.6	porB1a.l15.c30.ctg.2	383	28.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	117	119	AAT	12;12;11	A,G;A;T	11,1;12;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	300	porB1a	984	294	90.6	porB1a.l15.c30.ctg.2	383	28.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	141	143	GCA	12;12;12	G;C,T;A	12;11,1;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	300	porB1a	984	294	90.6	porB1a.l15.c30.ctg.2	383	28.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	164	166	GTA	14;13;13	G;T;A	14;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	300	porB1a	984	294	90.6	porB1a.l15.c30.ctg.2	383	28.3	0	.	p	.	0	S236N	NONSYN	706	708	AGC	170	172	AAC	14;14;14	A;A;C	14;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	300	porB1a	984	294	90.6	porB1a.l15.c30.ctg.2	383	28.3	0	.	p	.	0	.	MULTIPLE	709	711	AAC	174	178	TGGCG	14;15;20;21;23	T;G;G;C;G	13;14;18;19;20	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	300	porB1a	984	294	90.6	porB1a.l15.c30.ctg.2	383	28.3	0	.	p	.	0	D238A	NONSYN	712	714	GAT	180	182	GCT	24;25;28	G;C;T	21;22;26	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	300	porB1a	984	294	90.6	porB1a.l15.c30.ctg.2	383	28.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	240	242	TTA	49;50;50	T;T;A	42;44;44	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	300	porB1a	984	294	90.6	porB1a.l15.c30.ctg.2	383	28.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	285	287	CAT	54;53;50	C;A;T	46;46;45	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	300	porB1a	984	294	90.6	porB1a.l15.c30.ctg.2	383	28.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	288	290	AGT	49;50;50	A;G;T	45;45;45	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	300	porB1a	984	294	90.6	porB1a.l15.c30.ctg.2	383	28.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	297	299	TAC	50;51;51	T;A;C	45;45;45	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2558	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1516	167.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	436	438	GAA	230;228;229	G;A;A	208;210;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2558	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1516	167.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	847	849	TCA	182;184;182	T;C;A	166;167;166	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2558	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1516	167.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	976	978	GTC	203;203;205	G;T;C,A	185;185;189,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2558	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1516	167.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	988	990	TCT	203;202;204	T;C;T	188;187;188	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2558	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1516	167.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1306	1308	GCA	204;204;203	G;C;A	186;188;184	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2558	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1516	167.4	1	SNP	p	G120K	1	.	.	358	360	AAG	682	684	AAG	236;235;232	A;A;G	217;217;214	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2558	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1516	167.4	1	SNP	p	A121D	1	.	.	361	363	GAC	685	687	GAC	233;235;235	G;A,T;C	212;213,1;215	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2558	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1516	167.4	1	SNP	p	D121N	0	.	.	361	363	GAC	685	687	GAC	233;235;235	G;A,T;C	212;213,1;215	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	304	porB3	990	116	92.24	porB3.l15.c17.ctg.1	283	40.9	0	.	p	.	0	M18T	NONSYN	52	54	ATG	156	158	ACG	58;55;54	A;C;G	52;51;50	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	304	porB3	990	116	92.24	porB3.l15.c17.ctg.1	283	40.9	0	.	p	.	0	T29A	NONSYN	85	87	ACC	189	191	GCC	46;45;42	G;C;C	40;39;36	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	304	porB3	990	116	92.24	porB3.l15.c17.ctg.1	283	40.9	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	198	200	CAA	29;28;26	C,A;A;A	25,1;26;25	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	304	porB3	990	116	92.24	porB3.l15.c17.ctg.1	283	40.9	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	204	206	TAC	18;18;15	T;A;C	18;18;15	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9422	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4850	193.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	960	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	913	104.0	1	SNP	p	V57M	1	.	.	169	171	ATG	451	453	ATG	212;212;211	A;T;G,A	194;195;194,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
